Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer
Comprehensive surgery with adjuvant therapy is standard of care for high-risk endometrial cancers, whereas upfront radiotherapy with brachytherapy is indicated for inoperable/unresectable patients, irrespective of risk. We evaluated outcomes for inoperable/unresectable patients with high-risk endometrial cancer (HREC: stage III and/or grade 3) and low-risk endometrial cancer (LREC: stage I/II and grade 1/2) treated with upfront radiotherapy.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Bhavani S. Gannavarapu, Brian Hrycushko, Xun Jia, Kevin Albuquerque Source Type: research